IceCure Medical (ICCM)
(Real Time Quote from BATS)
$0.70 USD
-0.02 (-2.43%)
Updated Aug 26, 2024 01:00 PM ET
2-Buy of 5 2
F Value B Growth C Momentum D VGM
Cash flow Statements
Fiscal Year End for IceCure Medical Ltd falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -14.65 | -16.98 | -9.90 | -3.73 | -4.55 |
Depreciation/Amortization & Depletion | 0.32 | 0.25 | 0.13 | 0.06 | 0.03 |
Net Change from Assets/Liabilities | 0.52 | 0.21 | -3.16 | 0.20 | 2.52 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.29 | 2.22 | 0.32 | -0.22 | 0.01 |
Net Cash From Operating Activities | -12.52 | -14.29 | -12.61 | -3.69 | -1.99 |
Property & Equipment | -0.48 | -0.89 | -0.53 | -0.22 | -0.10 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.23 | 0.00 | 4.33 | -4.45 | 0.00 |
Net Cash from Investing Activities | -0.71 | -0.89 | 3.79 | -4.67 | -0.10 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.08 | 13.58 | 30.89 | 5.86 | 3.31 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.08 | 13.58 | 30.89 | 5.86 | 3.31 |
Effect of Exchange Rate Changes | 0.03 | -0.36 | 0.04 | 0.22 | 0.36 |
Net Change In Cash & Equivalents | -13.13 | -1.96 | 22.12 | -2.29 | 1.58 |
Cash at Beginning of Period | 23.66 | 25.62 | 3.50 | 5.79 | 4.21 |
Cash at End of Period | 10.53 | 23.66 | 25.62 | 3.50 | 5.79 |
Diluted Net EPS | -0.32 | -0.46 | -0.35 | -0.22 | NA |
Fiscal Year End for IceCure Medical Ltd falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -6.69 | -3.61 | -14.65 | -11.66 | -7.66 |
Depreciation/Amortization & Depletion | 0.17 | 0.09 | 0.32 | 0.24 | 0.16 |
Net Change from Assets/Liabilities | 0.83 | 0.38 | 0.52 | 0.33 | 0.17 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | NA | NA |
Other Operating Activities | 0.48 | 0.29 | 1.29 | 1.21 | 0.77 |
Net Cash From Operating Activities | -5.22 | -2.85 | -12.52 | -9.88 | -6.56 |
Property & Equipment | -0.03 | -0.03 | -0.48 | -0.40 | -0.32 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | NA | NA |
Investments | -0.31 | 0.53 | 0.00 | -9.37 | -13.65 |
Other Investing Activities | -0.01 | -0.01 | -0.23 | NA | NA |
Net Cash from Investing Activities | -0.35 | 0.49 | -0.71 | -9.77 | -13.97 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.73 | 2.84 | 0.08 | 0.02 | NA |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | NA | NA |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | NA | NA |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | NA | NA |
Other Financing Activities | NA | 0.00 | 0.00 | NA | NA |
Net Cash from Financing Activities | 4.73 | 2.84 | 0.08 | 0.02 | NA |
Effect of Exchange Rate Changes | -0.04 | -0.04 | 0.03 | -0.20 | -0.10 |
Net Change In Cash & Equivalents | -0.88 | 0.43 | -13.13 | -19.83 | -20.63 |
Cash at Beginning of Period | 10.53 | 10.53 | 23.66 | 23.66 | 23.66 |
Cash at End of Period | 9.65 | 10.97 | 10.53 | 3.83 | 3.03 |
Diluted Net EPS | -0.06 | -0.08 | -0.07 | -0.09 | -0.09 |